Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: A prospective study in adult and elderly patients with newly diagnosed partial epilepsy

Dogan E. A., Usta B. E., Bilgen R., ŞENOL Y., Aktekin B.

EPILEPSY & BEHAVIOR, cilt.13, sa.1, ss.156-161, 2008 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 13 Sayı: 1
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1016/j.yebeh.2008.02.001
  • Dergi Adı: EPILEPSY & BEHAVIOR
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.156-161
  • Anahtar Kelimeler: oxcarbazepine, monotherapy, elderly, newly diagnosed epilepsy-, intracerebral tumors, symptomatic epilepsy, Stevens-Johnson syndrome, CONTROLLED CLINICAL-TRIAL, ANTIEPILEPTIC DRUGS, BRAIN-TUMORS, SEIZURES, MANAGEMENT, SAFETY, RASH
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Objective. The aim of the study described here was to investigate the efficacy, tolerability, and side effects of oxcarbazepine (OXC) monotherapy in newly diagnosed, previously untreated adult and elderly patients with partial epilepsy.